Medicine
Rizatriptan 5 mg tablet
Rizatriptan 5 mg tablet is a generic prescription medicine for oral use, made by 12 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store rizatriptan benzoate tablets at 68°F to 77°F (20°C to 25°C) Dispense in…
Key facts
- Active ingredient (INN)
- Rizatriptan
- Brand
- Sold under the generic name
- Strength
- 5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 3 blister pack and 39 more
- Manufacturers
- Macleods PharmaceuticalsIndiaAscend LaboratoriesIndiaAurobindo PharmaIndiaCiplaIndiaUnichem LaboratoriesIndiaGlenmark PharmaceuticalsIndiaBryant Ranch PrepackCreekwood PharmaceuticalsDirect_RxRising Pharma Holdings12 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store rizatriptan benzoate tablets at 68°F to 77°F (20°C to 25°C) Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N02CC04 Rizatriptan
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 25 June 2012
- Identifiers
- RxCUI 312840, 314209DailyMed set ID f462a507-921c-41c2-93ba-36003b6e8914, 4ef60c83-ba48-4134-968b-13800ea9b7f2, 65ae33a2-975f-4a4e-a1a5-42fe451a2434 +14NDC 69097-865, 0093-7471, 71335-2031 +14Application ANDA204339, ANDA077263, ANDA203269 +5
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 12 labelers. The register lists 42 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 67877-261-01 | Ascend LaboratoriesIndia | 25 June 2012 |
| 500 tablet in 1 bottle | 67877-261-05 | Ascend LaboratoriesIndia | 25 June 2012 |
| 3 blister pack in 1 carton / 6 tablet in 1 blister pack | 67877-261-18 | Ascend LaboratoriesIndia | 25 June 2012 |
| 2 blister pack in 1 carton / 6 tablet in 1 blister pack | 67877-261-25 | Ascend LaboratoriesIndia | 25 June 2012 |
| 30 tablet in 1 bottle | 67877-261-30 | Ascend LaboratoriesIndia | 25 June 2012 |
| 4 blister pack in 1 carton / 3 tablet in 1 blister pack | 65862-599-12 | Aurobindo PharmaIndia | 31 December 2012 |
| 3 blister pack in 1 carton / 6 tablet in 1 blister pack | 65862-599-18 | Aurobindo PharmaIndia | 31 December 2012 |
| 3 blister pack in 1 carton / 3 tablet in 1 blister pack | 65862-599-90 | Aurobindo PharmaIndia | 31 December 2012 |
| 6 tablet in 1 blister pack | 69097-865-17 | CiplaIndia | 22 July 2016 |
| 3 tablet in 1 carton | 69097-865-85 | CiplaIndia | 22 July 2016 |
| 12 pouch in 1 carton / 1 blister pack in 1 pouch / 1 tablet in 1 blister pack | 68462-465-72 | Glenmark PharmaceuticalsIndia | 31 December 2012 |
| 30 tablet, film coated in 1 container | 33342-087-07 | Macleods PharmaceuticalsIndia | 11 March 2014 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 33342-087-12 | Macleods PharmaceuticalsIndia | 11 March 2014 |
| 3 blister pack in 1 carton / 6 tablet, film coated in 1 blister pack | 33342-087-41 | Macleods PharmaceuticalsIndia | 3 September 2018 |
| 2 blister pack in 1 carton / 6 tablet, film coated in 1 blister pack | 33342-087-45 | Macleods PharmaceuticalsIndia | 3 September 2018 |
| 200 tablet, film coated in 1 container | 33342-087-46 | Macleods PharmaceuticalsIndia | 11 March 2014 |
| 4 blister pack in 1 carton / 3 tablet, film coated in 1 blister pack | 33342-087-50 | Macleods PharmaceuticalsIndia | 11 March 2014 |
| 6 blister pack in 1 carton / 3 tablet, film coated in 1 blister pack | 33342-087-72 | Macleods PharmaceuticalsIndia | 11 March 2014 |
| 4 blister pack in 1 carton / 3 tablet in 1 blister pack | 29300-316-21 | Unichem LaboratoriesIndia | 5 July 2017 |
| 6 blister pack in 1 carton / 3 tablet in 1 blister pack | 29300-316-81 | Unichem LaboratoriesIndia | 5 July 2017 |
| 30 tablet in 1 bottle | 82619-111-01 | Creekwood Pharmaceuticals | 15 September 2023 |
| 1000 tablet in 1 bottle | 82619-111-02 | Creekwood Pharmaceuticals | 15 September 2023 |
| 2 blister pack in 1 carton / 6 tablet in 1 blister pack | 82619-111-04 | Creekwood Pharmaceuticals | 15 September 2023 |
| 3 blister pack in 1 carton / 6 tablet in 1 blister pack | 82619-111-05 | Creekwood Pharmaceuticals | 15 September 2023 |
| 4 blister pack in 1 carton / 3 tablet in 1 blister pack | 57237-087-34 | Rising Pharma Holdings | 31 December 2012 |
| 3 blister pack in 1 carton / 6 tablet in 1 blister pack | 57237-087-63 | Rising Pharma Holdings | 31 December 2012 |
| 18 blister pack in 1 box / 1 tablet in 1 blister pack | 0093-7471-43 | Teva Pharmaceuticals | 12 February 2013 |
| 30 tablet in 1 bottle | 71335-1149-1 | Bryant Ranch Prepack | 20 June 2019 |
| 18 tablet in 1 bottle | 71335-1149-2 | Bryant Ranch Prepack | 14 March 2019 |
| 12 tablet in 1 bottle | 71335-1149-3 | Bryant Ranch Prepack | 22 August 2023 |
| 30 tablet in 1 bottle | 71335-2031-1 | Bryant Ranch Prepack | 10 February 2022 |
| 18 tablet in 1 bottle | 71335-2031-2 | Bryant Ranch Prepack | 10 February 2022 |
| 30 tablet in 1 blister pack | 71335-2536-1 | Bryant Ranch Prepack | 10 December 2024 |
| 18 tablet in 1 blister pack | 71335-2536-2 | Bryant Ranch Prepack | 10 December 2024 |
| 12 tablet in 1 blister pack | 71335-2536-3 | Bryant Ranch Prepack | 10 December 2024 |
| 30 tablet in 1 bottle | 71335-2979-1 | Bryant Ranch Prepack | 6 November 2025 |
| 12 tablet in 1 bottle | 71335-2979-2 | Bryant Ranch Prepack | 6 November 2025 |
| 18 tablet in 1 blister pack | 61919-394-18 | Direct RX | 12 March 2018 |
| 18 tablet in 1 bottle | 72189-316-18 | Direct Rx | 20 January 2022 |
| 18 tablet in 1 bottle | 72189-512-18 | Direct_Rx | 11 September 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 29 June 1998 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Rizatriptan
Clinical summary
Rizatriptan is a serotonin-1b and serotonin-1d receptor agonist indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old, among other approved uses. MedsAcross supplies Rizatriptan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about RizatriptanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- MAXALT prescribing information (Organon) · U.S. National Library of Medicine, DailyMed
Need Rizatriptan 5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.